Evidence of P-glycoprotein sequence diversity in cyathostominsDROGEMULLER, Michaela; SCHNIEDER, T; VON SAMSON-HIMMELSTIERNA, G et al.The Journal of parasitology. 2004, Vol 90, Num 5, pp 998-1003, issn 0022-3395, 6 p.Article

Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforinWANG, Er-Jia; BARECKI-ROACH, Mary; JOHNSON, William W et al.Journal of pharmacy and pharmacology. 2004, Vol 56, Num 1, pp 123-128, issn 0022-3573, 6 p.Article

Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein effluxSHAN, Yong-Qiang; GANG REN; JIANG, Jian-Dong et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 3, pp 446-456, issn 0026-0495, 11 p.Article

New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitorsZHOU, Xiao-Fei; LINPING ZHANG; TSENG, Elaine et al.Drug metabolism and disposition. 2005, Vol 33, Num 3, pp 321-328, issn 0090-9556, 8 p.Article

Transcellular transport of aconitine across human intestinal Caco-2 cellsCUIPING YANG; ZHENG LI; TIANHONG ZHANG et al.Food and chemical toxicology. 2013, Vol 57, pp 195-200, issn 0278-6915, 6 p.Article

Anthelmintics Are Substrates and Activators of Nematode P GlycoproteinKERBOEUF, Dominique; GUEGNARD, Fabrice.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 5, pp 2224-2232, issn 0066-4804, 9 p.Article

P-glycoprotein function in the elderlyBRENNER, Stefanie S; KLOTZ, Ulrich.European journal of clinical pharmacology. 2004, Vol 60, Num 2, pp 97-102, issn 0031-6970, 6 p.Article

Characterization of a new antibody raised against the NH₂ terminus of P-glycoproteinRAO, Prema S; GOVINDARAJAN, Rajgopal; MALLYA, Kavita B et al.Clinical cancer research. 2005, Vol 11, Num 16, pp 5833-5839, issn 1078-0432, 7 p.Article

Identification of P-Glycoprotein Inhibitors in Contaminated Freshwater SedimentsZAJA, Roko; TERZIC, Senka; SENTA, Ivan et al.Environmental science & technology. 2013, Vol 47, Num 9, pp 4813-4821, issn 0013-936X, 9 p.Article

High Levels of P-Glycoprotein Activity in Human Lymphocytes in the First 6 Months of LifeGIRAUD, C; DECLEVES, X; SCHERRMANN, J. M et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 3, pp 289-295, issn 0009-9236, 7 p.Article

Genetic aspects of multidrug resistancePAULY, M; RIES, F; DICATO, M et al.Medical oncology and tumor pharmacotherapy. 1992, Vol 9, Num 1, pp 21-24, issn 0736-0118Article

Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytesCHAUDHARY, P. M; MECHETNER, E. B; RONINSON, I. B et al.Blood. 1992, Vol 80, Num 11, pp 2735-2739, issn 0006-4971Article

Réversion de la MultiDrug Resistance par inhibition de la glycoprotéine P = MultiDrug Resistance reversal through P-glycoprotein inhibitionROBERT, J.La Lettre du pharmacologue (Boulogne). 2011, Vol 25, Num 4, pp 157-161, issn 0984-452X, 5 p.Article

Quel rôle pour la glycoprotéine-P dans l'activité analgésique des opioïdes? = Function of P-glycoprotein in analgesic activity of opiatesJERDI, M. C; DESMEULES, J; DAYER, P et al.Douleur et analgésie. 2004, Vol 17, Num 2, pp 81-84, issn 1011-288X, 4 p.Article

Multichimiorésistance du mélanome uvéal = Multidrug résistance in uveal melanomaGAMBRELLE, J; LABIALLE, S; DAYAN, G et al.Journal français d'ophtalmologie. 2005, Vol 28, Num 6, pp 652-659, issn 0181-5512, 8 p.Article

Potential P-Glycoprotein-Mediated Drug-Drug Interactions of Antimalarial Agents in Caco-2 cellsOGA, Enoche F; SEKINE, Shuichi; SHITARA, Yoshihisa et al.The American journal of tropical medicine and hygiene. 2012, Vol 87, Num 1, pp 64-69, issn 0002-9637, 6 p.Article

Macelignan: A New Modulator of P-Glycoprotein in Multidrug-Resistant Cancer CellsYOUNG BIN IM; HA, Iiho; KEON WOOK KANG et al.Nutrition and cancer. 2009, Vol 61, Num 4, pp 538-543, issn 0163-5581, 6 p.Article

Functional role of P-glycoprotein in the human blood-placental barrierMÖLSÄ, Melissa; HEIKKINEN, Tuija; HAKKOLA, Jukka et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 2, pp 123-131, issn 0009-9236, 9 p.Article

Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetateCHENG WANG; ZHANG, Jin-Xia; SHEN, Xiao-Ling et al.Biochemical pharmacology. 2004, Vol 68, Num 5, pp 843-855, issn 0006-2952, 13 p.Article

Reversal of P-glycoprotein-associated multidrug resistance : the challenge continuesLEHNERT, M.European journal of cancer. Part A. 1993, Vol 29, Num 4, pp 636-638Article

Resistance ot tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cellsKAVALLARIS, M; MADAFIGLIO, J; NORRIS, M. D et al.Biochemical and biophysical research communications (Print). 1993, Vol 190, Num 1, pp 79-85, issn 0006-291XArticle

P-Selectin Glycoprotein Ligand-1 Contributes to Wound Healing Predominantly as a P-Selectin Ligand and Partly as an E-Selectin LigandTOMITA, Hajime; IWATA, Yohei; TAKENAKA, Motoi et al.Journal of investigative dermatology. 2009, Vol 129, Num 8, pp 2059-2067, issn 0022-202X, 9 p.Article

Evaluation of the Impact of P-Glycoprotein (P-gp) Drug Efflux Transporter Blockade on the Systemic and Ocular Disposition of P-gp SubstrateSENTHILKUMARI, Srinivasan; VELPANDIAN, Thirumurthy; BISWAS, Nihar R et al.Journal of ocular pharmacology and therapeutics. 2008, Vol 24, Num 3, pp 290-300, issn 1080-7683, 11 p.Article

A topological substructural approach for the prediction of P-glycoprotein substratesCABRERA, Miguel Angel; GONZALEZ, Isabel; FERNANDEZ, Carlos et al.Journal of pharmaceutical sciences. 2006, Vol 95, Num 3, pp 589-606, issn 0022-3549, 18 p.Article

Modulation of P-glycoprotein expression in hyperthyroid rat tissuesNISHIO, Naoki; KATSURA, Toshiya; ASHIDA, Kayoko et al.Drug metabolism and disposition. 2005, Vol 33, Num 11, pp 1584-1587, issn 0090-9556, 4 p.Article